Practice Variation Among Cardiovascular Physicians in Management of Patients With Mitral Regurgitation

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 255-261

  Harris, Kevin M ^a   Pastorius, Catherine A ^a   Duval, Sue ^a,b   Harwood, Eileen ^b   Henry, Timothy D ^a   Carabello, Blasé A ^c   Hirsch, Alan T ^a,b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DISEASE COURSE; E-MAIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PERSONNEL; MEDICAL SPECIALIST; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

CANADA; CHI-SQUARE DISTRIBUTION; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MITRAL VALVE INSUFFICIENCY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; UNITED STATES;

EID: 58149474638     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.09.065     Document Type: Article

References (28)

1. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease); Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). American College of Cardiology Web Site.
2. Jamieson W.R.E., Cartier P.C., Allard M., Boutin C., Burwash I.G., Butany J., de Varennes B., Del Rizzo D., Dumesnil J.G., Honos G., et al. Surgical management of valvular heart disease 2004. Can J Cardiol 20 (2004) 7E-120E
3. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., et al., Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
4. Zoghbi W.A., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., Nihoyannopoulos P., Otto C.M., Quinones M.A., Rakowski H., et al., American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with 2-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
5. Wennberg J.E., Fisher E.S., Goodman D.C., and Skinner J.S. Tracking the Care of Patients with Severe Chronic Illness: The Dartmouth Atlas for Health Care 2008 (2008), The Dartmouth Institute for Health Policy and Clinical Practice Center for Health Policy Research, Dartmouth Medical School, Lebanon, New Hampshire. http://www.dartmouthatlas.org/ Available at: http://www.dartmouthatlas.org/. Accessed June 14, 2008.
6. Jones E.C., Devereux R.B., Roman M.J., Liu J.E., Fishman D., Lee E.T., Welty T.K., Fabsitz R.R., and Howard B.V. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 87 (2001) 298-304
7. Society of Thoracic Surgeons. Executive Summaries and Sample Reports. www.sts.org/sections/stsnationaldatabase/publications/executive/article.html Accessed January 8, 2008
8. Ling L.H., Enriquez-Sarano M., Seward J.B., Tajik A.J., Schaff H.V., Bailey K.R., and Frye L. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335 (1996) 1417-1423
9. Grigioni F., Enriquez-Sarano M., Ling L.H., Bailey K.R., Seward J.B., Tajik A.J., and Frye R.L. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 34 (1999) 2078-2085
10. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., Detaint D., Capps M., Nkomo V., Scott C., Schaff H.V., and Tajik A.J. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 (2005) 875-883
11. Grigioni F., Tribouilloy C., Aviernos J.F., Barbieri A., Ferlito M., Trojette F., Tafanelli L., Branzi A., Szymanski C., Habib G., Modena M.G., Enriquez-Sarano M., and MIDA Investigators. Outcomes in mitral regurgitation due to flail leaflets: a multicenter European study. J Am Coll Cardiol Img 1 (2008) 133-141
12. Grayburn P.A. Should we operate on asymptomatic patients with severe mitral regurgitation?. J Am Coll Cardiol Img 1 (2008) 142-144
13. Rosenhek R., Rader F., Klaar U., Gabriel H., Krejc M., Kalbeck D., Schemper M., Maurer G., and Baumgartner H. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113 (2006) 2238-2244
14. Carabello B.A. Sudden death in mitral regurgitation: why was I so surprised?. J Am Coll Cardiol 34 (1999) 2086-2087
15. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 32 (1998) 1486-1588
16. Toledano K., Rudski L.G., Huynh T., Beique F., Sampalis J., and Morin J. Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol 23 (2007) 209-214
17. Dujardin K.S., Enriquez-Sarano M., Bailey K.R., Seward J.B., and Tajik A.J. Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol 87 (2001) 570-576
18. Harris K.M., Aeppli D.M., and Carey C.F. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. Am Heart J 150 (2005) 1106.e1-1106.e6
19. Harris K.M., Sundt III T.M., Aeppli D., Sharma R., and Barzilai B. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?. Ann Thorac Surg 74 (2002) 1468-1475
20. Grossi E.A., Crooke G.A., DiGiorgi P.L., Schwartz C.F., Jorde U., Applebaum R.M., Ribakove G.H., Galloway A.C., Grau J.B., and Colvin S.B. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation 114 (2006) 573-576
21. Levine R.A., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005) 745-758
22. Mihaljevic T., Lam B.K., Rajeswaran J., Takagaki M., Lauer M.S., Gillinov A.M., Blackstone E.H., and Lytle B.W. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49 (2007) 2191-2201
23. Barzilai B., Gessler Jr. C., Perez J.E., Schaab C., and Jaffe A.S. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol 61 (1988) 220-223
24. Lamas G.A., Mitchell G.F., Flaker G.C., Smith Jr. S.C., Gersh B.J., Basta L., Moyé L., Braunwald E., and Pfeffer M.A. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival And Ventricular Enlargement Investigators. Circulation 96 (1997) 827-833
25. Grigioni F., Enriquez-Saran M., Zehr K.J., Bailey K.R., and Tajik A.J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
26. Pastorius C.A., Henry T.D., and Harris K.M. Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol 100 (2007) 1218-1223
27. Pellizzon G.G., Grines C.L., Cox D.A., Stuckey T., Tcheng J.E., Garcia E., Guagliumi G., Turco M., Lansky A.J., Griffin J.J., et al. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 43 (2004) 1368-1374
28. Ellis S.G., Whitlow P.L., Raymond R.E., and Schneider J.P. Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. Am J Cardiol 89 (2002) 315-318